
Vita Life Sciences
Pharmaceuticals, Biotechnology & Life Sciences
Short position
Vita Life Sciences (ASX:VLS) has 0.00% of its shares on issue reported as short positions as of 21 Sept 2026, or about 114 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. VLS is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Vita Life Sciences (VLS) Short Interest
Vita Life Sciences (ASX:VLS) had 0.00% of shares reported as short positions as of 21 Sept 2026, representing 114 shares. Vita Life Sciences operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads VLS today
- Zanger BreakoutWatchScore 24rank 1088 of 1947
- CAN SLIMWatchScore 32rank 284 of 1540
- Minervini Trend TemplateWatchScore 44rank 377 of 1764
- Crowded-Short BreakoutWatchScore 12rank 826 of 1533
- Quality compoundersWatchScore 73rank 39 of 1688
Prices to 9 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
VLS fundamentals
In the 12 months to 30 Jun 2026, Vita Life Sciences (ASX:VLS) recorded revenue of A$96.0M and net profit after tax of A$11.2M. Year-on-year growth: revenue +17.3% (FY), EPS +19.4% (TTM). Net margin 11.6%, return on equity 20.5% (TTM). Figures are in AUD, the company's reporting currency; source: Yahoo Finance, as at 29 Sep 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Latest VLS news
All news- Notification of cessation of securities - VLS
asx · 7 Oct 2026
- Change of Director's Interest Notice
asx · 5 Oct 2026
- Update - Notification of buy-back - VLS
asx · 5 Oct 2026
About
website
address
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss VLS
Start a research thread or post the first pulse update